OSIP Related Analyst Ratings

Sep 15, 2009 06:43 AM Goldman Sachs Removes 'Sell' Rating On OSI Pharmaceuticals (OSIP), Ups to Neutral

Jun 24, 2009 08:05 AM Deutsche Bank Initiates Coverage on OSI Pharmaceuticals (OSIP) with a Hold

Jun 19, 2009 08:05 AM Oppenheimer Initiates Coverage on OSI Pharmaceuticals (OSIP)

May 27, 2009 12:34 PM RBC Capital Initiates Coverage on OSI Pharmaceuticals (OSIP) with a Sector Perform

Feb 10, 2009 12:19 PM OSI Pharma (OSIP) Receives Notification of ANDA Filing for Tarceva; Canaccord Analyst Says Patent Threat Remains an Overhang

Feb 10, 2009 10:59 AM Canaccord Adams Initiates Coverage on Several Life Sciences Stocks: ALTH, EXEL, MITI, NPSP, OSIP, ONXX, PARD, SGEN & SNTA

Feb 4, 2009 07:49 AM Goldman Sachs Downgrades OSI Pharmaceuticals Inc. (OSIP) to Sell

Nov 18, 2008 08:49 AM Cowen & Co Initiates Coverage on OSI Pharmaceuticals (OSIP) with a Neutral

Oct 21, 2008 11:19 AM Susquehanna Initiates Coverage on OSI Pharmaceuticals (OSIP) with a Positive

Jul 24, 2008 09:11 AM Piper Jaffray Increases Their Price Target on OSI Pharmaceuticals (OSIP) to $58

Apr 1, 2008 09:39 AM Piper Jaffray Adds OSI Pharma. (OSIP) to Alpha List

Mar 13, 2008 07:19 AM BMO Capital Initiates Coverage on OSI Pharmaceuticals (OSIP) with an Outperform

Mar 3, 2008 09:16 AM Wachovia Upgrades OSI Pharmaceuticals (OSIP) to Outperform

Feb 22, 2008 02:23 PM Buy OSI Pharmaceuticals (OSIP) on Weakness -Piper Jaffray

Jan 4, 2008 09:00 AM UBS Initiates Coverage on OSI Pharmaceuticals (OSIP) with a Buy

Jan 3, 2008 07:29 AM Lehman Bros. Downgrades OSI Pharmaceuticals (OSIP) to Equalweight

Dec 10, 2007 08:52 AM Merrill Lynch Downgrades OSI Pharmaceuticals (OSIP) to Neutral

Dec 4, 2007 08:26 AM Banc of America Initiates Coverage on OSI Pharmaceuticals (OSIP) with a Buy

Nov 30, 2007 11:09 AM Collins Stewart upgrades OSI Pharmaceuticals (OSIP) to Buy

Nov 15, 2007 03:49 PM Piper Jaffray raises its price target on OSI Pharmaceuticals (OSIP) to $50

Aug 28, 2007 07:29 AM Lehman Brothers upgrades OSI Pharma (OSIP) to Overweight

Aug 23, 2007 07:29 AM Wachovia upgrades OSI Pharma (OSIP) to Market Perform

Aug 14, 2007 07:10 AM JP Morgan upgrades OSI Pharma (OSIP) to Overweight

Apr 23, 2007 11:21 AM Rodman & Renshaw Comments on the "Aftershock" of MEDI/AZN Deal

Mar 22, 2007 08:14 AM Piper Jaffray Starts OSI Pharmaceuticals (OSIP) at Outperform

Nov 8, 2006 08:01 AM Banc of America downgrades OSI Pharma (OSIP) to Neutral

Oct 26, 2006 08:40 AM Lehman Brothers downgrades OSI Pharma (OSIP) to Underweight

Jun 2, 2006 12:57 PM OSI Pharmaceutical (OSIP) June option implied volatility above average into ASCO, July below average

Mar 27, 2006 11:38 PM Citigroup Highlights Biotech Day

Mar 6, 2006 07:11 AM Bear Stearns Upgrades OSIP to Outperform

Feb 23, 2006 07:27 AM Suntrust upgrades OSIP to Buy

Jan 23, 2006 07:47 AM Goldman Sachs Starts OSIP at In-Line

Nov 16, 2005 08:39 AM Smith Barney Initiates OSIP

Oct 18, 2005 01:25 PM Hearing CSFB Cut OSIP to Underperform

Oct 11, 2005 07:30 AM Bear Stearns Downgrades OSIP to Peer Perform

Sep 28, 2005 09:56 AM EYET Off Lows on Word OSIP Presentation Still On

Sep 12, 2005 10:55 AM Morgan Stanley Comments on OSIP

Aug 23, 2005 07:23 AM Wachovia Securities Downgrades OSIP

Aug 15, 2005 08:51 AM CSFB upgrades OSIP to Neutral

Jul 29, 2005 08:41 AM Suntrust Downgrades OSIP

Jul 12, 2005 03:57 PM OSIP Higher on Talk of Positive NEJM Articles

Jul 7, 2005 05:48 PM Banc of America Initiates Coverage on a Number of Biotech Stocks

Apr 6, 2005 08:00 AM Wachovia Securities Upped OSIP to Market Perform

Mar 28, 2005 09:21 AM UBS Cuts its Price Target on OSIP

Mar 15, 2005 11:12 AM BofA out in Defense of OSIP After Mid-Day Plunge

Mar 15, 2005 10:09 AM Lehman Brothers downgrades OSIP to Equal-Weight

Feb 9, 2005 07:21 AM First Albany Downgrades OSI Pharmaceuticals

Jan 25, 2005 01:01 AM BofA sees another massive potential indication for OSIP's Tarceva